1 rich Libsyn https://www.libsyn.com 90 600 In this episode of Bladder Cancer Matters, host and survivor Rick Bangs sits down with ImmunityBio’s Chief Medical Officer, Dr. Bobby Reddy, for a fascinating, hopeful look at the future of bladder cancer treatment. They unpack how next-generation immunotherapies like ANKTIVA—paired with innovative approaches to BCG—are reshaping care for patients, especially those with limited options, while also tackling real-world challenges like ongoing BCG shortages. Dr. Reddy breaks down the science in a way that’s accessible, highlighting how activating the body’s own immune system could lead to longer-lasting responses and even help patients avoid more invasive treatments. Tune in to this conversation about progress and possibility. Bladder Cancer Matters http://bladdercancer.libsyn.com/website <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/40826635/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/ef9a39/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/200693355